VAM
Visium Asset Management Portfolio holdings
AUM
$955M
1-Year Est. Return
4.5%
1 Year Est. Return
-4.5%
AUM
$5.59B
AUM Growth
-$665M
(-11%)
Holding
707
Top Buys
| 1 | +$104M | |
| 2 | +$99.3M | |
| 3 | +$68.8M | |
| 4 |
Humana
HUM
|
+$44.1M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$43.4M |
Top Sells
| 1 | +$57.7M | |
| 2 | +$57.1M | |
| 3 | +$43.3M | |
| 4 |
Zimmer Biomet
ZBH
|
+$41.4M |
| 5 |
NextEra Energy
NEE
|
+$37.8M |
Sector Composition
| 1 | Healthcare | 53.73% |
| 2 | Financials | 7.63% |
| 3 | Energy | 6.37% |
| 4 | Consumer Discretionary | 5.8% |
| 5 | Technology | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Labcorp
LH
$23.6B
| $280M | 4.77% |
2,786,063
-430,693
|
|
||
|
AGN
2
DELISTED
Allergan plc
AGN
| $264M | 4.49% |
984,910
-110,775
|
|
||
|
ENDP
3
DELISTED
Endo International plc
ENDP
| $188M | 3.2% |
6,680,749
+1,508,151
|
|
||
4
Pacira BioSciences
PCRX
$1.02B
| $119M | 2.02% |
2,239,098
-51,912
|
|
||
5
Centene
CNC
$17.5B
| $104M | 1.76% |
+3,367,454
|
|
||
6
Biogen
BIIB
$20.9B
| $99.3M | 1.69% |
+381,642
|
|
||
|
ZLTQ
7
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $78M | 1.33% |
2,871,762
+422,895
|
|
||
8
Neurocrine Biosciences
NBIX
$13.6B
| $73.7M | 1.25% |
1,864,222
-337,628
|
|
||
9
Cigna
CI
$77.7B
| $71.2M | 1.21% |
518,635
+271,053
|
|
||
10
Healthcare Realty
HR
$6.45B
| $70.1M | 1.19% |
2,382,215
-695,639
|
|
||
11
Gilead Sciences
GILD
$146B
| $69.1M | 1.18% |
752,693
+749,179
|
|
||
12
CONMED
CNMD
$1.39B
| $64.5M | 1.1% |
1,537,247
-269,768
|
|
||
13
Pfizer
PFE
$138B
| $63.6M | 1.08% |
2,262,318
+513,189
|
|
||
14
Align Technology
ALGN
$9.41B
| $58.4M | 0.99% |
803,625
+42,764
|
|
||
15
McKesson
MCK
$96.5B
| $58.4M | 0.99% |
371,173
+174,669
|
|
||
|
CBPO
16
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $55.5M | 0.94% |
484,619
+62,016
|
|
||
|
17
Humana
HUM
$32.1B
| $55.1M | 0.94% |
301,193
+240,995
|
|
||
|
SPNC
18
DELISTED
Spectranetics Corp
SPNC
| $52.2M | 0.89% |
3,592,940
+1,264,967
|
|
||
|
19
Zimmer Biomet
ZBH
$19.8B
| $51.9M | 0.88% |
501,285
-400,035
|
|
||
20
FibroGen
FGEN
$43.6M
| $50.3M | 0.86% |
94,550
+13,273
|
|
||
|
SAGE
21
DELISTED
Sage Therapeutics
SAGE
| $50M | 0.85% |
1,559,922
+484,613
|
|
||
|
22
Alnylam Pharmaceuticals
ALNY
$63.1B
| $49.7M | 0.85% |
792,295
+690,948
|
|
||
|
SIOX
23
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $48.1M | 0.82% |
524,096
-110,577
|
|
||
|
YHOO
24
DELISTED
Yahoo Inc
YHOO
| $48.1M | 0.82% |
1,305,704
-128,724
|
|
||
|
HZNP
25
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $46.5M | 0.79% |
2,804,261
-156,672
|
|